News

An Food and Drug Administration expert panel on Thursday endorsed removing the "black box" warning on hormone treatments for ...
( NewsNation) — The head of the U.S. Food and Drug Administration signaled Thursday that he supports changing or removing the ...
The culture of academic medicine needs to change, FDA Commissioner Marty Makary, MD, MPH, said at an event sponsored by The ...
Hormone therapy has endured a rather bumpy history after the Women’s Health Initiative published clinical trial data in 2002 ...
During a press conference on Monday, Food and Drug Administration Commissioner Marty Makary spoke about the agency's ...
FDA Commissioner Marty Makary's vision for the agency risks the best of an agency that mostly has functioned well for the ...
The FDA is reevaluating longtime warnings on hormone replacement therapy products for menopausal women. Some advocates for change say the so-called “black box” that lists health risks is discouraging ...
The FDA is reevaluating longtime warnings on hormone replacement therapy products for menopausal women. Some advocates for ...
It is unclear how the Trump administration will consider affordability when reviewing a drug, as prices are usually ...
According to Makary, reducing user fees—which make up just under half of the FDA's budget—could make it easier for smaller ...
Dr. Marty Makary, FDA commissioner, joins 'Squawk Box' to discuss what hindsight tells science about the best route to take ...
For decades, proponents of psychedelic drugs have come to Washington with a provocative message: Illegal, mind-altering ...